These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17430207)

  • 1. True antisense oligonucleotides with modified nucleotides restricted in the N-conformation.
    Koizumi M
    Curr Top Med Chem; 2007; 7(7):661-5. PubMed ID: 17430207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of sugar-modified oligonucleotides for antisense therapeutics.
    Prakash TP
    Chem Biodivers; 2011 Sep; 8(9):1616-41. PubMed ID: 21922654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of C-5 propynyl pyrimidine-containing oligonucleotides in vitro and in vivo.
    Shen L; Siwkowski A; Wancewicz EV; Lesnik E; Butler M; Witchell D; Vasquez G; Ross B; Acevedo O; Inamati G; Sasmor H; Manoharan M; Monia BP
    Antisense Nucleic Acid Drug Dev; 2003; 13(3):129-42. PubMed ID: 12954113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insight into antisense gapmer-RNA oligomer duplexes through molecular dynamics simulations.
    Uppuladinne MVN; Sonavane UB; Deka RC; Joshi RR
    J Biomol Struct Dyn; 2019 Jul; 37(11):2823-2836. PubMed ID: 30284504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
    Vester B; Wengel J
    Biochemistry; 2004 Oct; 43(42):13233-41. PubMed ID: 15491130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.
    Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F
    Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
    Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
    Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA): highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug.
    Morita K; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
    Bioorg Med Chem Lett; 2002 Jan; 12(1):73-6. PubMed ID: 11738576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Study Modeling Bridged Nucleic Acid-Based ASOs and Their Impact on the Structure and Stability of ASO/RNA Duplexes.
    Dowerah D; V N Uppuladinne M; Paul S; Das D; Gour NK; Biswakarma N; Sarma PJ; Sonavane UB; Joshi RR; Ray SK; Deka RC
    Langmuir; 2024 Oct; 40(41):21407-21426. PubMed ID: 39370641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triazole- and Tetrazole-Bridged Nucleic Acids: Synthesis, Duplex Stability, Nuclease Resistance, and in Vitro and in Vivo Antisense Potency.
    Mitsuoka Y; Yamamoto T; Kugimiya A; Waki R; Wada F; Tahara S; Sawamura M; Noda M; Fujimura Y; Kato Y; Hari Y; Obika S
    J Org Chem; 2017 Jan; 82(1):12-24. PubMed ID: 27936689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and properties of 2',4'-BNA(NC): a bridged nucleic acid analogue.
    Rahman SM; Seki S; Obika S; Yoshikawa H; Miyashita K; Imanishi T
    J Am Chem Soc; 2008 Apr; 130(14):4886-96. PubMed ID: 18341342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double sugar and phosphate backbone-constrained nucleotides: synthesis, structure, stability, and their incorporation into oligodeoxynucleotides.
    Zhou C; Plashkevych O; Chattopadhyaya J
    J Org Chem; 2009 May; 74(9):3248-65. PubMed ID: 19348480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'-Modified oligonucleotides for antisense therapeutics.
    Prakash TP; Bhat B
    Curr Top Med Chem; 2007; 7(7):641-9. PubMed ID: 17430205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of ENA Nucleotides and ENA Oligonucleotides.
    Morita K; Koizumi M
    Curr Protoc Nucleic Acid Chem; 2018 Mar; 72(1):4.79.1-4.79.21. PubMed ID: 29927121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of VEGF mRNA expression by 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) antisense oligonucleotides and investigation of non-target gene expression.
    Morita K; Yamate K; Kurakata S; Abe K; Imanishi T; Koizumi M
    Nucleic Acids Res Suppl; 2002; (2):99-100. PubMed ID: 12903124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and properties of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as effective antisense oligonucleotides.
    Morita K; Takagi M; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
    Bioorg Med Chem; 2003 May; 11(10):2211-26. PubMed ID: 12713831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) with nuclease-resistance and high affinity for RNA.
    Morita K; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
    Nucleic Acids Res Suppl; 2001; (1):241-2. PubMed ID: 12836354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ENA oligonucleotides as therapeutics.
    Koizumi M
    Curr Opin Mol Ther; 2006 Apr; 8(2):144-9. PubMed ID: 16610767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as next-generation antisense and antigene agents.
    Koizumi M
    Biol Pharm Bull; 2004 Apr; 27(4):453-6. PubMed ID: 15056846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antisense activity of ENA oligonucleotides targeting PTP1B mRNA in comparison of that of 2'-MOE-modified oligonucleotides.
    Koizumi M; Takagi-Sato M; Okuyama R; Araki K; Sun W; Nakai D
    Nucleic Acids Symp Ser (Oxf); 2007; (51):111-2. PubMed ID: 18029611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.